Abstract We evaluated the determinants of vessel contrast in prospectively ECG-triggered CT coronary angiography (CTCA). Seventy patients underwent low-dose CTCA using Body Mass Index (BMI)-adapted tube parameters and a fixed contrast material bolus. Contrast to noise ratio (CNR) was calculated from contrast (between coronaries and perivascular tissue) and image noise (standard deviation of aortic attenuation). Cardiac output (CO) was calculated from gated 99m Tc-tetrofosmin-SPECT. Mean radiation dose was 2.13 ± 0.69 mSv. Image noise was not affected by BMI (r = 0.1, P = 0.36), while CNR was inversely related to body surface area (BSA) (r = -0.5, P \ 0.001) and CO (r = -0.45, P \ 0.001). After successfully overcoming the impact of BMI on image noise by adapting tube parameters, CNR mainly depends on coronary vessel contrast. The latter reflects the dilution of the contrast material by blood volume and CO, which are both correlated to BSA. Therefore, BSA adapted contrast administration may help to compensate for this effect.
Introduction
Since the implementation of computed tomography coronary angiography (CTCA) with 64 slices, CTCA is an accurate method for non-invasive detection of coronary artery disease [1] [2] [3] [4] .
However, radiation exposure to patients and nondiagnostic image quality still remain issues of concern. Radiation exposure to patients can be reduced tremendously with prospective ECG-triggering as a new scanning protocol [5] . The use of this CTCA protocol allows to reduce radiation dose from about 15 mSv in spiral scanning with ECG-modulated tube current down to about 2 mSv [5] by administering radiation dose only at one predefined end-diastolic time point instead of during a whole phase of the cardiac cycle [6] .
Image quality is primarily affected by coronary calcification [1, 4, 7] , motion artifacts [1] [2] [3] 8] , body related factors (i.e., body mass index (BMI), body surface area (BSA)) [9] [10] [11] or by contrast bolus dilution depending on cardiac output (CO) [12] [13] [14] . Coronary calcifications are known to influence image quality by their blooming and beam-hardening artifacts [1, 4, 7] . Motion artifacts could be reduced by technical advances in new scanner generations such as subsecond rotation time and 64 [1] [2] [3] or more slices [15, 16] , but image quality is still affected by individual body-and hemodynamic-related parameters. According to previous studies, an increase in BMI induces higher image noise [9] [10] [11] while an increase in CO is associated with a decrease in coronary artery contrast [13] . The latter is most probably caused by more contrast dilution in coronary arteries.
In the present study we have adapted tube voltage and current to patients' BMI in order to minimize the interference of BMI with image noise and, thus, contrast to noise ratio (CNR). With this we aimed at assessing the impact of CO as an index of contrast bolus dilution on coronary artery attenuation and CNR.
Methods

Patients
Seventy consecutive patients (Table 1) Patients were referred because of suspected CAD (n = 64) based on at least one of the following symptoms such as dyspnoe (n = 11), typical angina pectoris (n = 10), atypical chest pain (n = 42), pathological exercise test or ECG (n = 20) or high cardiovascular risk factors (n = 2). Six patients with known CAD were referred for stent-control (n = 2) or follow-up after myocardial infarction (n = 4).
CT coronary angiography
All patients received a single dose of 2.5 mg isosorbiddinitrate sublingual (Isoket, Schwarz Pharma, Monheim, Germany) 2 min prior to the scan. In addition, intravenous metoprolol (2-20 mg) (Beloc, AstraZeneca, London, UK) was administered, if necessary to achieve a target heart rate under 65 bpm prior to the start of the scan. Heart rate was monitored. A fixed contrast material protocol was used in all patients, administering a bolus of 80 ml of iodixanol (Visipaque 320, 320 mg/ml, GE Healthcare) followed by 50 ml saline solution, which was continuously injected into an antecubital vein via an 18-gauge catheter at a flow rate of 5 ml/s. Bolus tracking was performed with a region of interest (ROI) placed into the ascending aorta. All CTCA examinations were performed on a LightSpeed VCT XT scanner (GE Healthcare) with prospective ECG-triggering [6] , using a commercially available protocol (SnapShot Pulse, GE Healthcare) and the following scanning parameters: slice acquisition 64 9 0.625 mm, smallest X-ray window . The effective radiation dose of CTCA was calculated as the product of the dose-length product (DLP) times a conversion coefficient for the chest (k = 0.017 mSv/mGycm) [17] . Axial images for attenuation calculations were reconstructed with a slice thickness of 0.6 mm, using a standard medium We performed the calculations of the CNR in the left main artery (LMA) as previously reported [13, 18] . Briefly, we first determined image noise by placing a ROI (2 9 2 cm) and measured the standard deviation of the attenuation value (in Hounsfield units, HU) in the ascending aorta. Second, ROIs were drawn as large as possible to measure attenuation in the proximal LMA and in the perivascular tissue, carefully avoiding calcifications, plaques, and stenoses. Vessel contrast was calculated as the difference in mean attenuation between the contrast enhanced vessel lumen and the adjacent perivascular tissue. Finally we calculated CNR as the ratio of vessel contrast over noise.
Myocardial perfusion imaging
MPI data acquisition was performed on a dual-head detector camera with the Hawkeye facility (Ventri, GE Healthcare), using a 1-day stress (0.14 mg/kg/ min adenosine i.v.)/rest protocol with a dose of approximately 300 and 900 MBq of 99m Tc tetrofosmin, respectively. Emission data were acquired with a parallel-hole, low-energy, high resolution collimator with a 20% symmetric window centered at 140 keV. Further acquisition parameters were 3°r otation per stop, 180°each head, and 25 s per projection. Acquisitions were gated for 16 frames per R-R cycle with an acceptance window of 50%. A low-dose, unenhanced CT for attenuation correction was acquired on a Light speed VCT XT scanner (GE Healthcare) and also used for coronary calcium socring, as previously reported in detail [19] .
Statistical analysis
Quantitative variables were expressed as mean ± SD and categorical variables as frequencies, or percentages. SPSS software (SPSS 15.0, Chicago, IL, USA) was used for statistical testing. The BSA was calculated with the common standard, i.e. Mosteller formula. Pearson correlation analyses were performed to compare image noise of the ascending aorta with BMI. Similarly attenuation and CNR in the LMA was compared with cardiac output and BSA. The 95% confidence intervals (CI) were plotted for the regression lines and were calculated for the slopes of regression line. A P value of\0.05 was considered to indicate a statistical significance. The study protocol was approved by the institutional review board and written informed consent was obtained.
Results
CTCA and MPI were successfully performed in all 70 patients on the same day. Intravenous betablocker was administered for heart rate control prior to CTCA in 46 patients (10.27 ± 5.58 mg, range 2.50-20.00 mg). The mean DLP from CTCA was 125.46 ± 40.68 mGycm (range: 58.39-189.36 mGycm) resulting in an estimated mean applied radiation dose of 2.13 ± 0.69 mSv (range: 0.99-3.22 mSv). This does not include the radiation dose of 64.91 ± 7.76 DLP (0.90 ± 0.45 mSv) from the unenhanced CT. (Fig. 1) .
The mean stroke volume was 56.23 ± 11.24 ml (range: 35.00-87.00 ml) and the mean heart rate during CT scanning 57.92 ± 7.22 bpm (range: 39.85-80.13 bpm). The calculated CO ranged from 1.84 to 4.45 ml/min and was inversely correlated to attenuation (LMA r = -0.50, P \ 0.001, SEE = 74.61) and CNR (r = -0.45, P \ 0.001, SEE = 72.71) (Fig. 2) . Moreover, CO was correlated to BSA (r = 0.58, P \ 0.001, SEE = 34.94). Figure 3 shows the impact of contrast bolus dilution in patients with different BSA and CO. There was no correlation between CNR and calcium score (P = non significant).
Discussion
CTCA image quality is impaired in patients with high BMI due to increased image noise and decreased coronary attenuation [9] [10] [11] 13] . In the present study we have minimized the impact of BMI on image noise, supporting that the adjustment of tube voltage and current was appropriate. As a consequence CNR mainly depended on coronary vessel attenuation. Despite BMI-adaption of the parameters above for noise reduction, vessel attenuation remained inversely correlated to BMI. The latter reflects that BMI is generally linked with blood volume and cardiac output, resulting in more contrast bolus dilution with higher BMI. Adjusting contrast administration to blood volume and cardiac output may compensate for this influence of dilution. As in daily clinical practice these parameters are often difficult to obtain, easily available alternatives would be more convenient. BSA is known to be a good indicator of metabolic active mass and therefore to be correlated to blood volume and CO. For this reason BSA is generally used for dosing of intravenous drugs, rather than BMI, which is more related to body fat. This may explain why BSA, reflecting CO and blood volume was slightly closer correlated to attenuation than CO Fig. 1 There was a significant inverse correlation between body surface area (BSA) and vessel attenuation (r = -0.56, P \ 0.001) as well as BSA and contrast to noise ratio (CNR) (r = -0.50, P \ 0.001) Fig. 2 There was a significant inverse correlation between cardiac output (CO) and vessel attenuation (r = -0.50, P \ 0.001) as well as CO and contrast to noise ratio (CNR) (r = -0.45, P \ 0.001) alone. It has therefore been theoretically suggested that contrast medium should be adjusted to BSA [9] . Our study confirms a close relationship between BSA and attenuation.
The use of a BMI-adapted scanning protocol allows the reduction of BMI-interference on image noise as evidenced by similar noise values over a large range of BMI. As mentioned above BSA is much closer related to blood volume and CO than BMI. In fact our results show that BSA is slightly stronger related to attenuation than BMI. Therefore, we conclude that the effect of dilution with decreased attenuation and CNR caused by an increasing blood volume and CO may be best compensated for by adaptation of contrast administration to BSA.
We acknowledge the following limitations. First, the amount of contrast material was not BMI-adapted in concordance with a large body of literature [1-4, 6, 8] , although suggested by a few previous reports [9, 10] . However, only the use of a fixed amount of contrast material enabled us to specifically evaluate the influence of BMI on image noise and coronary vessel attenuation. Second, coronary attenuation and CNR were selectively evaluated in the LMA, while distal segments were not evaluated, as the small diameters of distal segments do not allow reliably placing a ROI without including parts of the vessel wall and adjacent tissue thus causing partial volume effects.
Conclusion
Our results have shown that a BMI adapted protocol widely reduces the impact of BMI on image noise, while vessel contrast remains subject to large variations, depending on bolus dilution by blood volume and CO. Our study has identified BSA as the most promising parameter to be of potential value for adjusting the contrast bolus in future protocols. 
